Literature DB >> 18266176

Benign course of long-standing hepatitis B virus infection among Greenland Inuit?

Henrik Bygum Krarup1, Stig Andersen, Poul Henning Madsen, Henrik Okkels, Bodil Helenius Hvingel, Peter Laurberg.   

Abstract

OBJECTIVE: Chronic hepatitis B virus (HBV) infection can present in different ways, from inactive carrier to liver failure or cancer. The role of the virus subtype is controversial. The purpose of this study was to characterize HBV infection in detail and its impact on general health, body-build and liver biochemistry.
MATERIAL AND METHODS: The study comprised a population-based cohort of Inuit exposed to HBV 3-7 decades ago in the capital in West Greenland, a coastal town and four settlements in rural East Greenland. Participants included 95% of the invited Inuit: 229 men, 205 women, aged 50-69 years.
RESULTS: Only 25% of the participants had never had HBV infection. HBsAg was positive in 86 participants (20.0%), more being found positive in rural East Greenland than in the city in West Greenland (28.9% versus 2.7%; p < 0.001). HBV-DNA was positive in 61 of those with median HBV-DNA 40,000 copies/ml. HBV genotype could be determined in 52: 47 participants had genotype B, 4 genotype D, and 1 had both B and D. At sequencing, genotype B resembled subtype Bj, but with more than 5% diversity in the C-gene it could be a new subtype B. Pre-core mutation was found in 55 of 56 participants investigated. None of the participants had signs of liver disease, and HBV infection did not influence body-build or liver biochemistry.
CONCLUSIONS: More than 75% of participants had a marker of present or previous HBV infection but the infection seemed dormant. The majority harbored a special variant of genotype B that might be a new subtype giving a relatively benign disease. The role of detailed subtyping of HBV for prognostic evaluation should be investigated in more detail.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266176     DOI: 10.1080/00365520701712198

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

1.  Effectiveness of the targeted hepatitis B vaccination program in Greenland.

Authors:  Malene L Børresen; Anders Koch; Robert J Biggar; Karin Ladefoged; Mads Melbye; Jan Wohlfahrt; Tyra Grove Krause
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

Review 2.  Hepatitis B among Inuit: A review with focus on Greenland Inuit.

Authors:  Karsten Fleischer Rex; Stig Andersen; Henrik Bygum Krarup
Journal:  World J Hepatol       Date:  2015-05-28

3.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

Review 4.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

5.  Neglected infections of poverty among the indigenous peoples of the arctic.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

Review 6.  Chronic liver disease in Aboriginal North Americans.

Authors:  John D Scott; Naomi Garland
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

7.  Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.

Authors:  Thilde Nordmann Winther; Claus Heiner Bang-Berthelsen; Ida Louise Heiberg; Flemming Pociot; Birthe Hogh
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children.

Authors:  Thilde Nordmann Winther; Ida Louise Heiberg; Claus Heiner Bang-Berthelsen; Flemming Pociot; Birthe Hogh
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

9.  Burden and prevention of viral hepatitis in the Arctic region, Copenhagen, Denmark, 22-23 March 2012.

Authors:  David FitzSimons; Brian McMahon; Greet Hendrickx; Alex Vorsters; Pierre Van Damme
Journal:  Int J Circumpolar Health       Date:  2013-07-17       Impact factor: 1.228

10.  Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.

Authors:  Bo Langhoff Hønge; Sanne Jespersen; Candida Medina; David da Silva Té; Zacarias José da Silva; Sharon Lewin; Lars Østergaard; Christian Erikstrup; Christian Wejse; Alex Lund Laursen; Henrik Krarup
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.